KALARIS THERAPEUTICS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- KALARIS THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2023-06-30 was $70.17M.
- KALARIS THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2022-09-30 was $126.42M.
- KALARIS THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2020-09-30 was $291.98M.
- KALARIS THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2025 was $39.16M.
- KALARIS THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2023 was $70.17M, a 44.50% decline from fiscal 2022.
- KALARIS THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2022 was $126.42M.
- KALARIS THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2020 was $291.98M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $39.16M 10-K · filed 2026-03-17 | |
| 2023-12-31 | $70.17M 10-K · filed 2025-03-07 | |
| 2023-06-30 | $70.17M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $126.42M 10-K · filed 2024-03-15 | |
| 2022-09-30 | $126.42M 10-Q · filed 2023-11-02 | |
| 2020-12-31 | $291.98M 10-K · filed 2022-02-10 | |
| 2020-09-30 | $291.98M 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |